Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pre-S proteins in hepatitis B.

L Kuijpers1, M Koens, I Murray-Lyon

  • 1Scientific Development Group, Organon International BV, Oss, Netherlands.

Journal of Medical Virology
|May 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hodgkin's Disease in 50 Intravenous Drug Users with HIV-Infection.

Leukemia & lymphoma·2016
Same author

Selected Sumaries.

Acta clinica Belgica·2016
Same author

Viral hepatitis and haemophilia: an introduction.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Trials of Live Influenza Vaccine in the Royal Air Force.

British medical journal·2010
Same author

ABO Blood Groups and Acute Respiratory Virus Disease.

British medical journal·2010
Same author

Acute hepatitis.

British medical journal·2010
Same journal

Favipiravir Is Associated With Reduced 28-Day Mortality in Severe Fever With Thrombocytopenia Syndrome: A Multicenter Propensity Score-Matched Study.

Journal of medical virology·2026
Same journal

Defining Mechanistic Parameters for Covalent CD4-Based CAR-T Cells in HIV Reservoir Control.

Journal of medical virology·2026
Same journal

Development and Application of a Quadruplex TaqMan-MGB qPCR Assay for Simultaneous Detection of Important Mosquito-Borne Orthoflaviviruses.

Journal of medical virology·2026
Same journal

sVCAM-1 and Hematological Profiles Are Associated With CD4-Defined Disease Status in HIV Infection.

Journal of medical virology·2026
Same journal

An Explainable Machine Learning Model for Early Prediction of Incident Myocardial Injury in Patients With Severe Fever With Thrombocytopenia Syndrome.

Journal of medical virology·2026
Same journal

Global Performance of Human Papillomavirus Typing, Screening, and Evaluation As Assessed Using Proficiency Panels Traceable to International Standards: A Retrospective Analysis, 2008-2024.

Journal of medical virology·2026
See all related articles

Assaying pre-S1 and pre-S2 proteins in hepatitis B patients offers new diagnostic markers. These markers help assess infection and monitor treatment effectiveness, especially with interferon therapy.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis B virus (HBV) infection poses a significant global health challenge.
  • Accurate diagnostic markers are crucial for managing acute and chronic HBV infections.
  • Pre-S antigens are key components of the HBV surface antigen with potential diagnostic value.

Purpose of the Study:

  • To synthesize reactive sequences of hepatitis B surface antigen pre-S regions.
  • To develop and utilize micro-ELISAs for detecting pre-S1 and pre-S2 antigens in patient serum.
  • To evaluate the clinical utility of pre-S1 and pre-S2 antigen assays in hepatitis B patients.

Main Methods:

  • Chemical synthesis of hepatitis B surface antigen pre-S region sequences.
  • Development of micro-ELISA assays for pre-S1 and pre-S2 antigen detection.

Related Experiment Videos

  • Analysis of serum samples from patients with acute and chronic hepatitis B infections.

    • Main Results:

    • Pre-S1 antigen levels correlated strongly with the presence of HBV-DNA.
    • Pre-S1 antigen became undetectable upon cessation of viral replication, natural recovery, and successful interferon treatment.
    • Pre-S2 proteins were also found to be lost following alpha-interferon treatment.

    Conclusions:

    • Assays for pre-S1 and pre-S2 proteins serve as valuable additional markers in hepatitis B management.
    • These assays aid in assessing patients with acute and chronic hepatitis B.
    • Pre-S antigen detection is useful for monitoring therapeutic responses to interferon treatment.